{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:45:49Z","timestamp":1782377149064,"version":"3.54.5"},"reference-count":42,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Huons Biopharma, Republic of Korea"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Botulinum toxin type A (BTX-A) injection is a commonly used therapeutic intervention for upper limb spasticity in stroke patients. This study was designed as a randomized, active-drug-controlled, double-blind, multicenter, phase 3 clinical trial to evaluate the safety and efficacy of Liztox\u00ae in comparison to onabotulinum toxin A (Botox\u00ae) for individuals with post-stroke upper limb spasticity. The primary outcome was the alteration in wrist flexor muscle tone from the initial assessment to the fourth week, evaluated using the modified Ashworth scale (MAS). Secondary outcomes included MAS score changes for the wrist at weeks 8 and 12 from baseline; MAS score changes for finger and elbow flexors; and changes in the Disability Assessment Scale (DAS), Subject\u2019s Global Assessment (SGA), the Investigator\u2019s Global Assessment (IGA), and Caregiver Burden Scale (CBS) at weeks 4, 8, and 12 from baseline. The MAS score for wrist flexor spasticity decreased by \u22121.14 \u00b1 0.59 in the Liztox\u00ae group and \u22121.22 \u00b1 0.59 in the Botox\u00ae group from baseline to week 4. The difference [97.5% confidence interval (CI)] between the test and control groups was 0.08 [\u2212\u221e, 0.26], confirming the non-inferiority of the test group compared to the control group. Furthermore, there were consistent improvements in the IGA, SGA, and CBS scores across all assessment intervals, with no statistically significant variances detected between the two groups. No safety-related concerns were reported during the study. In conclusion, Liztox\u00ae injection proved to be a secure and efficacious intervention for managing upper extremity spasticity in post-stroke patients.<\/jats:p>","DOI":"10.3390\/toxins15120697","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T05:23:22Z","timestamp":1702358602000},"page":"697","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Randomized, Double-Blind, Active Control, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Liztox\u00ae versus Botox\u00ae in Post-Stroke Upper Limb Spasticity"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1050-2907","authenticated-orcid":false,"given":"Dong Hyun","family":"Ye","sequence":"first","affiliation":[{"name":"Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ho","family":"Chun","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Ghil","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06273, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5193-8678","authenticated-orcid":false,"given":"Nam-Jong","family":"Paik","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam 13620, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Uk","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Seoul 07061, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4513-2560","authenticated-orcid":false,"given":"Seung Don","family":"Yoo","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul 05278, Republic of Korea"},{"name":"Department of Medicine (AgeTech-Service Convergence Major), Kyung Hee University, Seoul 05278, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7622-6311","authenticated-orcid":false,"given":"Deog Young","family":"Kim","sequence":"additional","affiliation":[{"name":"Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jns.2013.02.027","article-title":"Depression, activities of daily living and quality of life in patients with stroke","volume":"328","author":"Haghgoo","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/096382899297684","article-title":"Disablement following stroke","volume":"21","author":"Mayo","year":"1999","journal-title":"Disabil. Rehabil."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1747-4949.2012.00969.x","article-title":"Stroke disability and rehabilitation of stroke: World Health Organization perspective","volume":"8","author":"Mendis","year":"2013","journal-title":"Int. J. Stroke"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/STROKEAHA.110.604090","article-title":"Early prediction of outcome of activities of daily living after stroke: A systematic review","volume":"42","author":"Veerbeek","year":"2011","journal-title":"Stroke"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1191\/0269215502cr512oa","article-title":"Prevalence of spasticity post stroke","volume":"16","author":"Watkins","year":"2002","journal-title":"Clin. Rehabil."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1468-1331.2011.03448.x","article-title":"A literature review of the pathophysiology and onset of post-stroke spasticity","volume":"19","author":"Ward","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1212\/01.WNL.0000141863.52691.44","article-title":"Oral antispastic drugs in nonprogressive neurologic diseases: A systematic review","volume":"63","author":"Vallano","year":"2004","journal-title":"Neurology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.pmrj.2009.07.015","article-title":"Intrathecal baclofen therapy: An update","volume":"1","author":"Francisco","year":"2009","journal-title":"PMR"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00002060-199907000-00010","article-title":"Mechanisms of Action of Phenol Block and Botulinus Toxin Type a in Relieving Spasticity: Electrophysiologic Investigation and Follow-Up: 1","volume":"78","author":"On","year":"1999","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/WNL.46.5.1306","article-title":"Botulinum toxin type A in the treatment of upper extremity spasticity: A randomized, double-blind, placebo-controlled trial","volume":"46","author":"Simpson","year":"1996","journal-title":"Neurology"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Demetrios, M., Khan, F., Turner-Stokes, L., Brand, C., and McSweeney, S. (2013). Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity. Cochrane Database Syst. Rev., 5.","DOI":"10.1002\/14651858.CD009689.pub2"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/ageing\/27.2.239","article-title":"Management of spasticity","volume":"27","author":"Barnes","year":"1998","journal-title":"Age Ageing"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Lee, J., and Chun, M.H. (2022). Safety and Efficacy of HU-014 in the Treatment of Post-Stroke Upper Limb Spasticity: A Phase I Pilot Study. Toxins, 14.","DOI":"10.3390\/toxins14110730"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Scaglione, F. (2016). Conversion ratio between Botox\u00ae, Dysport\u00ae, and Xeomin\u00ae in clinical practice. Toxins, 8.","DOI":"10.3390\/toxins8030065"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00702-007-0869-3","article-title":"Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity","volume":"115","author":"Rosales","year":"2008","journal-title":"J. Neural Transm."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jns.2015.07.028","article-title":"Efficacy and safety of NABOTA in post-stroke upper limb spasticity: A phase 3 multicenter, double-blinded, randomized controlled trial","volume":"357","author":"Nam","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/STROKEAHA.110.582197","article-title":"Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial: Effect on impairment, activity limitation, and pain","volume":"42","author":"Shaw","year":"2011","journal-title":"Stroke"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000083259","article-title":"Botulinum toxin: Mechanisms of action","volume":"53","author":"Dressler","year":"2005","journal-title":"Eur. Neurol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.apmr.2003.10.015","article-title":"Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke","volume":"85","author":"Childers","year":"2004","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1177\/0269215516689331","article-title":"Safety and efficacy of letibotulinumtoxinA (BOTULAX\u00ae) in treatment of post stroke upper limb spasticity: A randomized, double blind, multi-center, phase III clinical trial","volume":"31","author":"Do","year":"2017","journal-title":"Clin. Rehabil."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Seo, H.G., Paik, N.-J., Lee, S.-U., Oh, B.-M., Chun, M.H., Kwon, B.S., and Bang, M.S. (2015). Neuronox versus BOTOX in the treatment of post-stroke upper limb spasticity: A multicenter randomized controlled trial. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0128633"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa011892","article-title":"Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke","volume":"347","author":"Brashear","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/09638280500535165","article-title":"Relation between spasticity, weakness and contracture of the elbow flexors and upper limb activity after stroke: An observational study","volume":"28","author":"Ada","year":"2006","journal-title":"Disabil. Rehabil."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/16501970600609808","article-title":"Correlation between impairment and motor performance during reaching tasks in subjects with spastic hemiparesis","volume":"38","author":"Leonard","year":"2006","journal-title":"J. Rehabil. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/PL00007851","article-title":"Efficacy of botulinum toxin A in upper limb function of hemiplegic patients","volume":"249","author":"Rousseaux","year":"2002","journal-title":"J. Neurol."},{"key":"ref_26","first-page":"51","article-title":"Treatment of upper extremity spasticity in stroke patients by focal neuronal or neuromuscular blockade: A systematic review of the literature","volume":"34","author":"Geurts","year":"2002","journal-title":"Database Abstr. Rev. Eff. (DARE) Qual.-Assess. Rev. [Internet]"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S1474-4422(15)00216-1","article-title":"Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: A double-blind randomised controlled trial","volume":"14","author":"Gracies","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"86","author":"Simpson","year":"2016","journal-title":"Neurology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jnnp.69.2.217","article-title":"Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: A randomised double blind placebo controlled trial","volume":"69","author":"Bhakta","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jns.2016.10.005","article-title":"Botulinum toxin as early intervention for spasticity after stroke or non-progressive brain lesion: A meta-analysis","volume":"371","author":"Rosales","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"ref_31","first-page":"256","article-title":"Efficacy and safety of botulinum toxin type A for upper limb spasticity after stroke or traumatic brain injury: A systematic review with meta-analysis and trial sequential analysis","volume":"53","author":"Dong","year":"2016","journal-title":"Eur. J. Phys. Rehabil. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.apmr.2012.12.006","article-title":"Treatment with botulinum toxin improves upper-extremity function post stroke: A systematic review and meta-analysis","volume":"94","author":"Foley","year":"2013","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1590\/S0004-282X2007000400008","article-title":"Does botulinum toxin improve the function of the patient with spasticity after stroke?","volume":"65","author":"Cardoso","year":"2007","journal-title":"Arq. Neuro-Psiquiatr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2340\/16501977-0366","article-title":"Botulinum toxin A for treatment of upper limb spasticity following stroke: A multicentre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes","volume":"41","author":"McCrory","year":"2009","journal-title":"J. Rehabil. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12640-015-9565-5","article-title":"Neutralizing antibody and botulinum toxin therapy: A systematic review and meta-analysis","volume":"29","author":"Fabbri","year":"2016","journal-title":"Neurotox. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/mus.25721","article-title":"Effects of repeated abobotulinumtoxinA injections in upper limb spasticity","volume":"57","author":"Gracies","year":"2018","journal-title":"Muscle Nerve"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"fcaa201","DOI":"10.1093\/braincomms\/fcaa201","article-title":"When can maximal efficacy occur with repeat botulinum toxin injection in upper limb spastic paresis?","volume":"3","author":"Gracies","year":"2021","journal-title":"Brain Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1212\/01.WNL.0000144349.95487.91","article-title":"Repeated dosing of botulinum toxin type A for upper limb spasticity following stroke","volume":"63","author":"Gordon","year":"2004","journal-title":"Neurology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1053\/apmr.2002.35474","article-title":"Inter-and intrarater reliability of the Ashworth Scale and the Disability Assessment Scale in patients with upper-limb poststroke spasticity","volume":"83","author":"Brashear","year":"2002","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ptj\/67.2.206","article-title":"Interrater reliability of a modified Ashworth scale of muscle spasticity","volume":"67","author":"Bohannon","year":"1987","journal-title":"Phys. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/1531-8257(200009)15:5<973::AID-MDS1031>3.0.CO;2-X","article-title":"Botulinum toxin antibody testing: Comparison between the mouse protection assay and the mouse lethality assay","volume":"15","author":"Dressler","year":"2000","journal-title":"Mov. Disord."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1006\/taap.1994.1181","article-title":"Measurement of botulinum toxin activity: Evaluation of the lethality assay","volume":"128","author":"Pearce","year":"1994","journal-title":"Toxicol. Appl. Pharmacol."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/15\/12\/697\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:37:11Z","timestamp":1760132231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/15\/12\/697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,12]]},"references-count":42,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["toxins15120697"],"URL":"https:\/\/doi.org\/10.3390\/toxins15120697","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,12]]}}}